GRP78 has previously been associated with ovarian cancer[29,30], and our results from the iTRAQ analysis indicate that this protein may potentially be a good biomarker for ovarian tumors since there was no overlap in expression levels between the benign and the malignant samples (p = 0.005). Here, HSPA5 is linked to ovarian cancer.